###begin article-title 0
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NFkappaB Activation
###end article-title 0
###begin p 1
Conceived and designed the experiments: PZ Yang L CD CW. Performed the experiments: CD Yan L YW BP. Analyzed the data: PZ Yang L CD CW. Wrote the paper: PZ Yang L CD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
B1 B cells are believed to be a unique lineage with a distinct developmental pathway, function and activation requirement. How this lineage is genetically determined remained largely obscure.
###end p 3
###begin title 4
Methods and Principal Findings
###end title 4
###begin p 5
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Using the Siglecg-deficient mice with a knockin of green-fluorescent protein encoding sequence, we show here that, although the Siglecg gene is broadly expressed at high levels in all stages and/or lineages of B cells tested and at lower levels in other lineages, its deletion selectively expanded the B1a B cell lineages, including the frequency of the B1 cell progenitor in the bone marrow and the number of B1a cells in the peritoneal cavity, by postnatal expansion. The expansion of B1a B cells in the peritoneal correlated with enhanced activation of NFkappaB and was ablated by an IKK inhibitor.
###end p 5
###begin title 6
Conclusion and Significance
###end title 6
###begin p 7
Our data revealed a critical role for Siglec G-NFkappaB pathway in regulating B1a B cell lineage. These data lead to a novel model of B1a lineage development that explains a large array of genetic data in this field.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy1">[1]</xref>
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Kantor1">[2]</xref>
###xml 241 244 241 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy2">[3]</xref>
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hayakawa1">[4]</xref>
###xml 411 414 411 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hayakawa2">[5]</xref>
###xml 561 566 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6</italic>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Sidman1">[6]</xref>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6</italic>
###xml 802 805 802 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pao1">[7]</xref>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C-Rel</italic>
###xml 858 867 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF&#954;B1</italic>
###xml 956 959 948 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pohl1">[8]</xref>
###xml 1331 1334 1323 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-OKeefe1">[9]</xref>
###xml 1336 1340 1328 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Otipoby1">[10]</xref>
###xml 1342 1346 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pan1">[11]</xref>
###xml 1348 1352 1340 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Sato1">[12]</xref>
An important choice a B cell makes is whether to become B1a B cells that produce poly-reactive natural IgM, B1b cells that make adaptive IgM response, or conventional B2 B cells that primarily mediate T-dependent adaptive immunity [1], [2], [3]. While extensive studies have revealed critical roles for the B cell receptor (BCR) recognition, such as its self-reactivity, in determining the lineage choices [4], [5], accumulating evidence indicate that the size of B1 B cells are likely regulated by other factors. For instance, naturally occurring mutations of Ptpn6 which encodes Shp1 leads to dramatic increase of the B1a B cell compartment [6]. Recent studies using lineage-specific deletion of the Ptpn6 gene demonstrated a B cell-intrinsic function of SHP1 in limiting the size of the B1a B cells [7]. On the other hand, targeted mutations of C-Rel and NFkappaB1, two components of NFkappaB complex, leads to a significant reduction of the B1 B cells [8]. How these intracellular signaling pathways are used by cell surface molecular interactions to regulate the size of B1 B cell lineage is largely unknown. In particular, targeted mutation of genes encoding several potential membrane proteins that can associate with SHP1, including those of CD72 and CD22, did not substantially impact the development of B1 B cell lineage [9], [10], [11], [12].
###end p 9
###begin p 10
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Crocker1">[13]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Kitzig1">[14]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Whitney1">[15]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Oetke1">[16]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Li1">[17]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Munday1">[18]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Kitzig1">[14]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Whitney1">[15]</xref>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
Of particular interest are members of the sialic acid-binding, immunoglobulin-like lectin family, or Siglec, many of which have ITIM Motifs for association with SHP1 [13]. Several members of the families, including Siglec 10, the human orthologue of Siglec G, have been demonstrated to be associated with SHP1 [14], [15]. While targeted mutation of Sialoadhesin reduced IgM level, this mutation does not appear to affect the B1 B cell lineage [16]. Siglec G and its human orthologue Siglec 10 appears to have several alternative splicing variants [17], [18][14], [15]. All variants, however, shared the same cytoplasmic domain with the ITIM motif capable of interacting with SHP-1, which was known to be a negative regulator for B1B cell lineages. Since the function and expression of Siglec G have not been characterized in detail, we produced Siglec G-deficient mice with a knockin of GFP open-reading frame to report its expression. Our results revealed that Siglec G is expressed at high levels at essentially all stages of B cell development and significant but reduced levels in other cell lineages. Importantly, targeted mutation of the Siglec G gene dramatically expanded the B1a B cell lineages postnatally, by increasing NFkappaB activation. Our data revealed Siglec G is a molecular checkpoint that limits the postnatal expansion of B1a B cells by repressing NFkappaB activation.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
GFP-knock-in mice reveal wide-spread expression of Siglecg in multiple lineages
###end title 12
###begin p 13
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Munday1">[18]</xref>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 428 435 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 567 575 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s001">Fig. S1A</xref>
###xml 859 867 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s001">Fig. S1B</xref>
###xml 1060 1067 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1097 1105 1097 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s001">Fig. S1C</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
Previous studies using flow cytometry have suggested that Siglec 10 may be expressed in subsets of human leukocytes including eosinophils, monocytes and a minor population of natural killer-like cells [18]. Because of the alternative splicing, it is unclear whether these data reflect specific alternative spliced variants. To investigate the cell lineage in which the Siglecg locus is active while studying the function of the Siglecg in vivo, we replaced essentially all coding exons of the Siglecg sequence with a GFP coding sequence, as diagramed in Supplemental Fig. S1A. The genomic DNA clones were isolated from C57BL/6j DNA library for homologous recombination in the ES cells of C57BL/6 origin. The neomycin-resistant ES cell clones were screened for homologous recombination. The clone that was ultimately used for blastocyte injection was shown in Fig. S1B. The chimera mice were continuously bred in B6 background and the offspring shows typical Mendalian distribution of +/+, +/- and -/- genotypes (data not shown). The deletion of the endogenous Siglecg genomic sequence is shown in Fig. S1C.
###end p 13
###begin p 14
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
Since the GFP cDNA is fused into exon 2 of the Siglecg gene, its expression is controlled by the regulatory elements of the Siglecg locus. We therefore used the expression of GFP to report transcription of Siglecg. The gene dose effects are measured by comparing the +/- and -/- littermates.
###end p 14
###begin p 15
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Christensen1">[19]</xref>
###xml 197 204 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000997-t001">Table 1</xref>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g001">Fig. 1A</xref>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy3">[20]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy4">[21]</xref>
###xml 389 396 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 410 417 410 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g001">Fig. 1B</xref>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 505 512 505 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g001">Fig. 1C</xref>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 640 647 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g001">Fig. 1C</xref>
###xml 735 742 735 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g001">Fig. 1D</xref>
###xml 799 806 799 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
The hematopoeitic cells in the bone marrow were identified as FLSK subset, which are Lin-Flt2-Sca1+and c-Kit+[19]. The size of the HSC does not differ among the littermates of the three genotypes (Table 1). Nevertheless, the locus is transcribed in the HSC, albeit at lower levels (Fig. 1A). The Pre-Pro/Pro B cells, as defined by IgM-B220loCD43+[20], [21], expressed higher levels of the Siglecg transcripts (Fig. 1B). Among the spleen cells, the B cells (B220+) expressed the highest levels of Siglecg (Fig. 1C). However, significant levels were also detected in DC (CD11c+), myeloid cells (CD11b+), and to a less extent, T cells (CD3+) (Fig. 1C). We further analyzed the GFP levels among the major known B cell subsets. As shown in Fig. 1D, essentially all known subsets expressed high levels of Siglecg. Interestingly, heterogeneity of GFP levels was found at all subsets of hematopoeitic cells studied, starting at the HSC.
###end p 15
###begin title 16
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg.</italic>
Transcription of the Siglecg locus as determined by the expression of GFP which was used to replace the coding sequence of Siglecg.
###end title 16
###begin p 17
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 457 458 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 481 482 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 507 508 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 527 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 636 629 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
Red, WT; green heterozygous; blue, homozygous. A. Low levels of GFP expression among the hematopoeitic cells. The left panel shows the profiles of Lin-Flt2-Sca-1+C-Kit+ hematopoeitic stem cells (HSC), while the right panel depicts the GFP intensity of the gated HSC. B. Expression of the Siglecg locus in the pre-Pro/Pro B cells. As in A, except that the IgM-CD43+B220lo cells were depicted. C. Transcription of the Siglecg locus among splenic B cells (B220+), myeloid cells (CD11b+), dendritic cells (CD11c+) and T cells (CD3+). The top panel shows summary data, while the lower panels show representative FACS profiles. D. The Siglecg locus is actively transcribed at all stage/lineages of B cells, as in C. Data shown in this Figure represents 2 mice per group, and has been repeated twice.
###end p 17
###begin title 18
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Selective expansion of B1a cells in the peritoneal of the Siglecg-deficient mice.
###end title 18
###begin p 19
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Paul1">[27]</xref>
The cell subsets were phenotyped as described [27]. For BM HSC cells, N = 3. For spleen and peritoneal cavity T cells, N = 6. For all other cells, N = 12.
###end p 19
###begin p 20
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
Taken together, our data demonstrated that the Siglecg locus is transcribed in essentially all the major cell types in the hematopoeitic cell types analyzed, although B cells, as a group, seem to have the highest levels.
###end p 20
###begin title 21
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
Targeted mutation of Siglecg leads to preferential expansion of B1a B cells in the peritoneal cavity
###end title 21
###begin p 22
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000997-t001">table 1</xref>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g002">Fig. 2A</xref>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g002">Fig. 2B</xref>
###xml 661 668 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000997-t001">table 1</xref>
###xml 752 759 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g002">Fig. 2B</xref>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
Given the wide-spread expression of Siglecg, we determined whether targeted mutation of the gene affects the development of different compartments of the hematopoeitic cells by flow cytometry. As shown in table 1, the compositions of the major hematopoeitic subsets, including HSC, T cells, myeloid cells, dendritic cells and different stages of B cells, were comparable between the WT and the mutant mice. Surprisingly, we have observed a 5-fold increase in the size of B1a cells in the peritoneal, although the number of B1b subset was unchanged (Fig. 2A). The number of B1a cells in the spleen, however, did not differ in adult mice (Fig. 2B lower panel and table 1), although a two fold expansion of spleen B1 B cells can be observed at two weeks (Fig. 2B, upper panel).
###end p 22
###begin title 23
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Selective expansion of peritoneal cavity B1a cells in mice with targeted mutation of the Siglecg gene.
###end title 23
###begin p 24
###xml 555 563 555 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 683 686 <span type="species:ncbi:31658">CFA</span>
A. Expansion of B1a, but not B1b subsets. The top panel shows the profile of B cells among peritoneal lavages of 10 weeks old mutant and age-matched WT controls, while the lower panel shows summary data involving 10 mice per group. This experiment has been repeated 5 times involving a total of 10-12 mice per group. C. Serum concentration of different isotypes of Ig, note substantial increase of IgM and decrease of IgG1 in the mutant mice. Data shown in the lower panels are Means+SEM, with 20 mice per group. D. Adaptive B cell response in WT and the Siglecg-deficient mice. The WT and Siglecg-deficient mice were immunized with 200 microg of OVA in complete Freunds' adjuvants (CFA) on day 0, boosted with the same amounts of OVA on day 7. Sera were collected on day 1, 7 and 14 for measurement of anti-OVA antibodies by ELISA using the OVA-coated plate. Data shown are means+SEM of optical density, n = 6. Sera were used at 1:500 dilutions for the ELISA.
###end p 24
###begin p 25
###xml 97 104 97 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g002">Fig. 2C</xref>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 461 468 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g002">Fig. 2D</xref>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
Corresponding to the expansion of the B1a cells, the levels of serum IgM increased by 5-10 fold (Fig. 2C). With exception of IgG1, which is reduced by approximately 2-fold, the levels of other Ig isotypes was unaffected by Siglecg deletion. To determine whether deletion of Siglecg affects adaptive B cell responses, we immunized the WT and Siglecg-deficient mice with OVA and determined the antibody levels at one and two weeks after immunization. As shown in Fig. 2D, the antibody response was essentially unaffected by the Siglecg deletion.
###end p 25
###begin title 26
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 46 56 46 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Postnatal expansion of B1a progenitors in the Siglecg-/- mice
###end title 26
###begin p 27
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy2">[3]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-MontecinoRodriguez1">[22]</xref>
###xml 497 504 497 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s002">Fig. S2</xref>
###xml 826 834 826 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siglecg-</italic>
###xml 1073 1080 1073 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1220 1228 1220 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 1272 1273 1272 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1301 1308 1301 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s003">Fig. S3</xref>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
It is generally believed that the B1a progenitors give rise to mature B1a cells during fetal development and that self-renewal of the B1a cells after birth explains the long-life persistence of the B1a lineage [3]. More recently, a low number of B1a progenitor cells were identified in mature bone marrow [22]. In order to explain the drastic difference in the number of B1a cells in the peritoneal cavity, we carried out BrdU labeling to determine the proliferation of the B1a cells. As shown in Fig. S2, at two weeks, when a significant difference was observed in the % of B1a B cells found in the spleen, the rate of BrdU incorporation was the same in the two groups. Conversely, at 10 weeks, when no difference in the B1a subsets was observed in the spleen, there appeared to be a higher rate of BrdU incorporation in the siglecg-deficient mice. Furthermore, in the peritoneal cavity, where a dramatic difference of the number of B1a cells were found, the rate of BrdU incorporation was essentially identical. Thus, while our data did not rule out the possibility that Siglecg may regulate B1a proliferation in specific locations, such function does not account for the differential accumulation of B1a cells in the Siglecg-deficient mice. Likewise, the % of Annexin V+ cells was also comparable (Fig. S3). Thus, neither increased self-renewal nor decreased apoptosis of mature B1a cells explain the expansion of the B1a compartment.
###end p 27
###begin p 28
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 350 352 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 411 412 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 416 418 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-MontecinoRodriguez1">[22]</xref>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g003">Fig. 3A</xref>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 691 698 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g003">Fig. 3B</xref>
###xml 794 802 794 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g003">Fig. 3C</xref>
###xml 946 953 946 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siglecg</italic>
###xml 964 973 964 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g003">Fig. 3A&#8211;C</xref>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
To explore the possibility that increased number of B1a cells may be due to the expansion of the B1 progenitors, we compared the number of the progenitors in the fetal liver and adult bone marrow. The Lin-AA4.1+ liver and bone marrow mononuclear cells can be further divided into 4 subsets by their expression of B220 and CD19. Among them, CD19+ B220lo subsets are considered the B1a progenitors, while the CD19-B220hi subsets are regarded as the B2 progenitors [22]. As shown in Fig. 3A, the number of B1a progenitors in the E16.5-E17 fetal livers was unaffected by Siglecg mutation. Likewise, the number of B1a progenitor in the newborn livers was also similar between WT and mutant mice (Fig. 3B). In contrast, the number of B1 progenitors was expanded by 4-fold in the bone marrow of adult Siglecg-deficient mice, in comparison to what was found in the WT littermates (Fig. 3C). In either compartment, the B2 progenitors were not affected by siglecg mutation (Fig. 3A-C).
###end p 28
###begin title 29
Postnatal expansion of B1a but not B2 progenitor cells.
###end title 29
###begin p 30
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
A. Progenitor cells from fetal liver. B. Progenitor cells from new born liver cells. C. Percentage of B1 (CD19+B220lo) and B2 (CD19-B220hi). Data shown in A involve 2 WT and 2 mutant mice per group. Data shown in B involve 3 WT and 4 mutant mice per group. Similar levels were found in 12 heterozygous littermates. C. As in A, except 10 week old bone marrow were analyzed. N = 7.
###end p 30
###begin p 31
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siglecg</italic>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 191 201 191 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>+/+</sup></italic>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 219 229 219 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 318 308 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6</italic>
###xml 379 382 379 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pao1">[7]</xref>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 466 456 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 473 480 473 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s004">Fig. S4</xref>
###xml 709 716 709 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g004">Fig. 4A</xref>
###xml 768 771 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 761 771 761 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
To determine whether the adult bone marrow from the siglecg-deficient mice have increased tendency to reconstitute the B1a compartment, we mixed equal numbers of total bone marrow cells from Siglecg+/+ (CD45.1) and the Siglecg-/- (CD45.2) mice, and adoptively transferred them into lethally irradiated WT or Siglecg-/- host. Unlike the mice with B cell-specific deletion of Ptpn6[7], no expansion of B1a cells was found in the bone marrow was found in the Siglecg-/- mice (Fig. S4), therefore no effort was made to delete the B1a cells from bone marrow. Thirteen weeks after bone marrow transplantation, the bone marrow, peritoneal cavity and spleen were harvested and analyzed by flow cytometry. As shown in Fig. 4A, regardless of the recipient genotypes, the Siglecg-/- bone marrow were more efficient in reconstituting the B cell compartment, including Pre-ProB/Pro and Pre/new B cells, and the total number of B cells. In contrast, bone marrows from the two genotypes were comparably efficient in reconstituting the myeloid compartment.
###end p 31
###begin title 32
Siglecg-deficient bone marrow cells have competitive advantages in reconstituting bone marrow B cell lineage and peritoneal B1a subsets in lethally irradiated recipients.
###end title 32
###begin p 33
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 510 512 510 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 547 555 547 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low-high</sup>
###xml 558 561 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 766 773 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
The WT (CD45.1) and Siglecg-/- (CD45.2) bone marrow cells were mixed at a 1:1 ratio and used to reconstitute the lethally irradiated mice, 13 weeks later, the mice were sacrificed for analysis. The bone marrow and peritoneal lavages were analyzed by flow cytometry for reconstitution by WT and mutant bone marrow cells. A. Summary data showing the contribution of WT (open bars) and mutant bone marrow cells (filled bars). The cell subsets in bone marrow include total B cells (B220+), Pre-pro/Pro B (CD43+B220losIgM-) and pre/new B (CD43-B220+IgMlow-highIgDlow). The lower panel summarizes the total B cells and B1a B cells in the peritoneal lavages. Data shown are mean+SEM, N = 5. B. Representative profiles depicting the relative contribution of WT (CD45.1) and Siglecg-deficient (CD45.2) cells to the B1a compartment. C. Representative profiles depicting distinct profile of WT and Siglecg-deficient B1a cells.
###end p 33
###begin p 34
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 201 208 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g004">Fig. 4A</xref>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g004">Fig. 4B</xref>
###xml 784 787 784 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 777 787 777 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 1022 1029 1022 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s005">Fig. S5</xref>
###xml 1152 1155 1152 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pao1">[7]</xref>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
Importantly, in the peritoneal cavity, the number of Siglecg-/- B1a cells was 2-3 fold more abundant than that from the WT bone marrow, while the number total B cells were not significantly different (Fig. 4A lower panel and Fig. 4B). In addition to the difference in the total number, an interesting difference in the cell surface markers was also observed. Thus, the majority of the B1a cells derived from WT bone marrow expressed high CD5, essentially all of the B1a cells from the mutant bone marrow exhibited low levels of CD5. The increased number of progenitor cells in the adult bone marrow, but not in fetal liver, and over-presentation of mutant B1a cells in the peritoneal cavity strongly suggests that the expansion of the B1a cells in the peritoneal cavity of the Siglecg-/- mice was due to postnatal expansion of the B1a cells, perhaps due to increased frequency of B1a progenitor cells. Interestingly, unlike the peritoneal cavity, the number of B1a cells in the spleen is mainly derived from the WT donor (Fig. S5). Such phenotype is reminiscent of a recently reported phenotype associated with SHP-1 mutation in the B cell compartment [7].
###end p 34
###begin title 35
###xml 116 119 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 119 105 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Activation of NFkappaB is essential for the expansion of the B1a compartment in the peritoneal cavity of the Siglecg-/- mice
###end title 35
###begin p 36
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6</italic>
###xml 444 447 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Sidman1">[6]</xref>
###xml 572 575 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pohl1">[8]</xref>
###xml 615 622 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 668 675 656 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g005">Fig. 5A</xref>
###xml 708 715 696 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 864 871 844 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g005">Fig. 5A</xref>
###xml 966 973 942 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g005">Fig. 5B</xref>
###xml 1092 1099 1064 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1130 1137 1102 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g005">Fig. 5C</xref>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
We compared ex vivo WT and Siglecg-deficient peritoneal cavity cells for activation of a number of signal transduction pathways, including phosphorylation of Akt, Stat 3, Stat 5, P38, Erk and JNK. Our extensive analyses fail to reveal a significant difference between the WT and mutant cells (Data not shown). Since mutation of Ptpn6, which associate with Siglecg orthologue Siglec 10, enhanced NFkappaB activation and expanded B1a compartment [6], and since mice with targeted mutation of components in NFkappaB pathway show selective reduction of B1a B cell compartment [8], we focused on the potential impact of Siglecg deletion on NFkappaB activation. As shown in Fig. 5A, ex vivo peritoneal lavage from Siglecg-deficient mice show greatly increased IkappaBalpha phosphorylation in the cytosol and nuclear accumulation of P65, as demonstrated by Western blot (Fig. 5A). This corresponds to greater binding to NFkappaB probe as revealed by mobility shift assays (Fig. 5B). Furthermore, the increased NFkappaB function was revealed by luciferase assay when the peritoneal cells from WT and Siglecg-deficient mice were compared (Fig. 5C).
###end p 36
###begin title 37
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglec<sup>&#8722;/&#8722;</sup></italic>
Siglec-/- peritoneal cavity lavage cells have increased NFkappaB activity.
###end title 37
###begin p 38
###xml 313 315 309 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
A. Western blot analysis of cytosolic total and phorsphorylated IkBa (upper panels) and nuclear P65, using the amounts of SP1 as loading control (lower panels). B. EMSA analysis of nuclear NFkappaB activity. Nuclear lysates from WT (+/+) or knockout peritoneal lavages were prepared and tested for retardation of 32P NFkB probe. The specificity of the gel retardation was confirmed by super-shift with anti-P50 or P65 antibodies. C. Luciferase activity of peritoneal cells from WT and knockout mice. Data shown in this figure have been repeated twice.
###end p 38
###begin p 39
###xml 108 111 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 101 111 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 260 267 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 390 394 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Park1">[23]</xref>
###xml 408 415 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g006">Fig. 6A</xref>
###xml 773 780 749 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g006">Fig. 6B</xref>
###xml 937 940 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 930 940 902 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
The increased IkappaBalpha phosphorylation indicated enhanced IKK activity in the B1a cells from the Siglecg-/- peritoneal cavity. To determine whether the activation of NFkappaB is essential for the expansion of the B1a compartment, we treated the 5-days old Siglecg-deficient mice with IkappaB kinase complex (IKK) inhibitor VI, which we have demonstrated to work efficiently in the mice [23]. As shown in Fig. 6A, consecutive treatment resulted in greatly decreased IkappaBalpha phosphorylation and nuclear P65 accumulation. Importantly, the percentage and number of B1a cells in the peritoneal cavity was reduced by 3-4 folds in the treated group. In contrast, despite effective inhibition of IKK, the number of B1a cells in the spleen was unaffected by the inhibitor (Fig. 6B). These results reveal that activation of the NFkappaB pathway is essential for selective expansion of the B1a cells in the peritoneal cavity of the Siglecg-/- mice.
###end p 39
###begin title 40
IKK inhibitor treatment decreased B-1a cells in peritoneal cavity but not spleen.
###end title 40
###begin p 41
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
(A). Efficacy of the treatment in reducing IKK activity among total spleen cells as revealed by IkappaBalpha phosphorylation in the cytosol (upper panel) P65 accumulation in the nuclei (lower panel) of spleen cells from treated or control mice. B. The impact of inhibiting the IKK on peritoneal B1a subsets. Data shown are means+SEM involving 5-6 mice per group.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy1">[1]</xref>
###xml 203 206 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Kantor1">[2]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy2">[3]</xref>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 388 395 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
A long-standing observation in immunology is the preferential accumulation of B1a B cell in the peritoneal cavity. Given the importance of the B1a B cells in innate immunity and autoimmune diseases [1], [2], [3], the mechanisms that determine the size of B1a B cell subsets in the locality are of great interest. Using mice with targeted mutation of the Siglecg gene, we demonstrate that Siglecg controls B1 B cell expansion in the peritoneal cavity by repressing NFkappaB activation.
###end p 43
###begin title 44
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
Siglecg controls a checkpoint for peritoneal B1a B cell expansion
###end title 44
###begin p 45
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
We have observed mice with targeted mutation of Siglecg that had a 5-10 fold increase in serum IgM, while those of most other Ig isotypes were roughly normal. In search for a cellular basis for the over-production of IgM, we uncovered the dramatic expansion of the B1 B cells in the peritoneal cavity. Of the two subsets of B1 B cells in the cavity, the expansion is limited to the CD11b+ B1a subsets. Moreover, while the expansion of the B1a B cells in the peritoneal cavity were observed throughout the study, the expansion of the B1 B cells in the spleen is only transient, observable at 2 weeks but not 10 week.
###end p 45
###begin p 46
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 474 481 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Since no reagent is currently available to study the protein expression for mouse Siglecg, we used a GFP knockin transgenic line to determine the expression of Siglecg. Our data indicated that while cells among B cell lineage had the highest levels of Siglecg expression, essentially all major subsets of hematopoeitic cells examined, including T cells, DC, and monocytes show active transcription of the locus. Despite the wide-spread expression of the gene, the impact of Siglecg deletion appear to be limited to the B1a B cells in the peritoneal cavity, although a smaller expansion of the B1a B cells in the spleen can be observed at 2 weeks of age.
###end p 46
###begin p 47
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hoffmann1">[24]</xref>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
While our manuscript was in preparation, Hoffmann et al. [24] reported a Siglecg-deficient mouse prepared with ES cells from the BALB/c. While they observed expansion of B1a cells in the spleen and peritoneal cavity, the B1a expansion observed in our study is more selective. The difference in background genes between the two strains of mice may account for the difference.
###end p 47
###begin title 48
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Postnatal expansion of B1a progenitors and expansion of B1 B cells in the Siglecg-deficient mice
###end title 48
###begin p 49
###xml 99 102 99 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hardy2">[3]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-MontecinoRodriguez1">[22]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Tung1">[25]</xref>
###xml 577 585 577 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 947 950 947 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 940 950 940 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup></italic>
###xml 1008 1015 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1196 1202 1196 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglec</italic>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
While the B1a B cells are generally believed to have been produced from progenitors in fetal liver [3], recent studies identified B1a progenitors in adult bone marrow [22][25]. Therefore, the expansion of the B1a B cell compartment can theoretically be attributed to either increased fetal production or postnatal production. Our analysis of adult progenitor cells in the bone marrow and fetal livers indicated a substantial increase in the B1a B progenitors in the bone marrow, but not in the fetal or new born liver. Consistent with the increased B1a B progenitor cells, the Siglecg-deficient bone marrow are more efficient in constituting the B1a B cells. These data, together with the fact that neither increased proliferation nor decreased apoptosis explains the expansion of B1a B cells in the peritoneal cavity, supports the notion that postnatal expansion of the B1a compartment is responsible for the expansion of B1a cells in the Siglecg-/-mice. Therefore, our data demonstrate a novel function of Siglecg in regulating postnatal expansion of the B1a compartment. It remains to be determined as to whether the expansion is intrinsic to genetic defects in the precursor cells, or due to Siglecg defects in other cell types.
###end p 49
###begin p 50
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siglecg</italic>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 606 614 606 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
It is worth pointing out that although the number of progenitors for B2 cells were not increased, the siglecg-deficient bone marrow was more efficient in reconstituting B cells than the WT bone marrow when they were mixed with WT bone marrow cells. These data suggest that in addition to the number of B1 B progenitors, Siglecg exerts a general repressive effect on the differentiation of the B cell compartment. Such requirement, however, seems to be reflected in competition with progenitor cells from the WT host, but not with other cell lineage, as the relative number of B cells are the same when the Siglecg-deficient mice were analyzed.
###end p 50
###begin title 51
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 37 42 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 92 96 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shp1</italic>
Siglecg is a negative regulator of NFkappaB activity in peritoneal B cells: similarity with Shp1
###end title 51
###begin p 52
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 263 268 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 318 326 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg-</italic>
###xml 1198 1200 1162 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1252 1256 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hoffmann1">[24]</xref>
###xml 1377 1379 1341 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Our comparison between WT and Siglecg-deficient ex vivo peritoneal lavage revealed that activation of a number of signaling pathways, including AKT, STAT, Erk, P38 and JNK was not affected by the mutation (data not shown). In contrast, a profound activation of NFkappaB was observed in the peritoneal lavages from the Siglecg-deficient mice in comparison to that from WT mice, as indicated by increased phosphorylation of IkappaB, nuclear localization of P65, increasing mobility shift of the NFkappaB probe and increased promoter activity when the NFkappaB reporter constructs were used to transfect the peritoneal lavage cells. Since the activation correlates with the IkappaB phosporlation, it is likely that the conical NFkappaB pathway is being activated. Moreover, since the IKK is responsible for IkappaB phosphorylation, we used the IKK inhibitor VI to block NFkappaB activation in order to study the significance of this activation in B1a cell expansion in the peritoneal cavity. Our data clearly demonstrated that activation of NFkappaB is responsible for the expansion of the B1a cells in the peritoneal cavity. Recently, Hoffmann et al. reported that mutant B cells display increased Ca2+ signaling in responses to several stimuli in vitro [24]. Since it is unclear if these stimuli are responsible for the B1a expansion in vivo, the significance of the enhanced Ca2+ response remains to be demonstrated.
###end p 52
###begin p 53
###xml 727 734 727 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s002">Fig. S2</xref>
Interestingly, despite the significant effect of the IKK inhibitor for spleen cells, no increase in the spleen B1a B cells were observed. These data clearly indicated that expansion of B1a B cells in the peritoneal cavity uses a mechanism that is not employed to maintain the number of spleen B1a B cells. The selective expansion of B1a B cells from the mutant peritoneal cavity suggests that the expansion requires both unique checkpoint in the specific cell lineage and specific stimuli in the peritoneal cavity. Moreover, we have observed no effect of IIKK inhibitor on BrdU incorporation in B1a cells (data not shown). However, since our data also indicated that the expansion cannot be demonstrated by BrdU incorporation (Fig. S2), the cellular basis for the increase remains to be determined.
###end p 53
###begin p 54
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shp1</italic>
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pao1">[7]</xref>
###xml 234 241 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6.</italic>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Kitzig1">[14]</xref>
###xml 920 924 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Whitney1">[15]</xref>
###xml 1140 1147 1140 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6</italic>
###xml 1160 1169 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF&#954;B1</italic>
###xml 1174 1179 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C-rel</italic>
###xml 1199 1206 1195 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg</italic>
###xml 1250 1254 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Hoffmann1">[24]</xref>
###xml 1320 1323 1316 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Pao1">[7]</xref>
###xml 1567 1571 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Park1">[23]</xref>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 866 871 <span type="species:ncbi:9606">human</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
Recently, Rajewsky and colleagues demonstrated that targeted mutation of Shp1 in the B cell lineage causes expansion of B1a B cells in the peritoneal cavity [7]. Remarkable similarity can be found between the germline mutation of the Siglecg and B-cell specific deletion of Ptpn6. Firstly, in terms of lineage size, the impact of mutation is limited within B1a B cells in the peritoneal cavity. Secondly, the expansion of B1a subsets is due to the postnatal expansion of B1a cells. Thirdly, in bone marrow chimera mice, the mutant bone marrow shows a remarkable advantage in reconstituting the peritoneal B1a B cells, while displaying a disadvantage in constituting spleen B1a B cell compartment. These similarities in functional defects raise the possibility that the gene has a similar function within B cell compartment. Since Siglc10, the Siglec G orthologue in human, has been shown to be associated with Shp1[14], [15], the simplest hypothesis is that Shp1 works down-stream of Siglec G in limiting the controlled expansion of B1a subset. This hypothesis has the potential to unify observations made from mice with genetic defects of Siglecg, Ptpn6, and NFkappaB1 and C-rel. Since mutation of Siglecg increases the titer of anti-DNA antibodies [24] and since deletion of Shp1 in B cells causes autoimmune diseases [7], the balance of the Siglecg signaling will likely be important in the proper tuning of the B1a function in innate immunity against infection vs. autoimmune side effect. Given recent advances in pharmaceutical targeting of the NFkappaB pathway [23], our study suggests a new approach in selective tuning of innate immunity and autoimmunity.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup>GFP<sup>+/+</sup></italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Generation of Siglecg-/-GFP+/+ mice using C57BL/6 ES cells
###end title 56
###begin p 57
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 22 38 22 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup>GFP<sup>+/+</sup></italic>
###xml 187 194 187 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s001">Fig. S1</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
The production of the Siglecg-/-GFP+/+ mice is carried out by the Ingenious Research Laboratory, Inc. (Long Island, New York) under a research contract. Detail information is provided by Fig. S1. Briefly, a approximately9.8 kb region used to construct the targeting vector was first sub cloned from a positively identified BAC clone using a homologous recombination-based technique. The region was designed such that the short homology arm (SA) extends 1.8 kb 3' to exon 11. The long homology arm (LA) ends in exon 2 just before the ATG and is approximately8.8 kb long. The GFP/Neo cassette (Neo is flanked by both loxP and FRT sites) is inserted before the ATG of Exon 2 and replaces approximately5 kb of the gene sequence including exons 3-11.
###end p 57
###begin p 58
###xml 714 722 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s001">Fig. S1B</xref>
###xml 980 983 980 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 986 989 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 973 989 973 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg<sup>&#8722;/&#8722;</sup>GFP<sup>+/+</sup></italic>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
Ten micrograms of the targeting vector was linearized by AscI and then transfected by electroporation of iTL C57/Bl6 embryonic stem cells. After selection in G418, surviving clones were expanded for PCR analysis to identify recombinant ES clones. Primers, A1, 2 and 3 were designed downstream (3') to the short homology arm (SA) outside the region used to generate the targeting construct. PCR reactions using A1, 2 or 3 with the N1 primer at the 5' end of the Neo cassette amplify 2.0, 2.0 and 2.1kb fragments respectively. The control PCR reaction was done using AT1 and AT2, which is at the 5' end of the SA inside the region used to create the targeting construct. This amplifies a band of 1.7 kb. As shown in Fig. S1B, Individual clone was screened with A1/N1, A2/N1 and A3/N1 primers. ES clone #361 was identified as a recombinant clone and injected into BALB/c blastcytes. The chimera mice were bred to B6 mice to obtain F1 mice, which were intercrossed to generate Siglecg-/-GFP+/+ mice, and their WT and heterozygous littermates.
###end p 58
###begin title 59
Isotype specific ELISA
###end title 59
###begin p 60
###xml 141 145 <span type="species:ncbi:9925">goat</span>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
###xml 667 678 <span type="species:ncbi:3704">Horseradish</span>
Serum immunoglobulin titers were determined by enzyme-linked immunosorbent assay (ELISA) using BD Falcon plates (BD biosciences) coated with goat anti-mouse immunoglobulin (2 microg/ml; Southern Biotechnology, Birmingham, AL) diluted in sodium bicarbonate buffer (pH 8.2). Standard curves of each Ig isotype were generated with purified mouse IgM, IgG1, IgG2a, IgG2b and IgG3 (Southern Biotechnology). Plates were blocked with 1% non-fat milk in PBS for 1 h at room temperature, and sera were diluted in blocking buffer (1% non-fat milk in PBS) (IgM and IgG1, 1:10,000; IgG2a, IgG2b and IgG3,1:5,000) and allowed to bind to the plate for 2 hours at room temperature. Horseradish isotype-specific antibodies (Southern Biotechnology) were then added after washing with 0.05% Tween 20 in PBS and then substrate Sigma Fast OPD (Sigma Aldrich, St. Louis, MO). Optical densities at 490 nm were measured with a fluorescence plate reader (SpectroMax 190, Molecular Devices, Toronto, Canada).
###end p 60
###begin title 61
Flow cytometry
###end title 61
###begin p 62
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Single-cell suspensions were prepared from tibial bone marrow, spleen and peritoneal cavity from mice euthanized with CO2. Cells were suspended in RPMI 1640. Prior to staining, red cells in spleens were lysed (BD Pharm Lyse, BD biosciences). Cells were then suspended in PBS with 2% FBS and 1% sodium azide for staining. Cells were surface stained for 30 minutes at 4oC and intracellular staining of BrdU is done following manufacturer (BD Pharmingen) provided protocol. Cells were then suspended in staining buffer and transferred for flow cytometry (BD LSR II, BD biosciences). Analysis of the flow cytometry data was done with Flowjo 7.2. Antibodies used were either purchased from BD Pharmingen (La Jolla, CA): (B220, APC-Cy7 streptavidin, c-kit, Sca-1, CD21, CD5, CD19, and Lin markers, CD3, Gr-1, CD11b, Ter119) or purchased from EBioscience (La Jolla, CA), CD23 and AA4.1.
###end p 62
###begin title 63
Western blot
###end title 63
###begin p 64
Cells were lysed by regular lysis buffer containing 1% Triton-X100, 1:100 diluted, protein and phosphatase cocktails ( both from Sigma). Nuclear and cytoplasmic proteins were isolated by a nuclear and cytoplasmic protein extraction kit (Pierce Biotechnology, Rockford, IL). Antibodies for western-blot are phospho-antibodies of p-AKT, p-GSK3beta, p-p38, p-p42/44, p-JNK, p-IkappaB, p-p65, p-Stat3, and p-Stat-5, all from Cell Signaling, and corresponding control antibodies of GSK3alpha/beta, IkappaBalpha, from Cell Signaling (Davers, MA), and those specific for p-65, and Sp1 from Santa Cruz Biotechnology (Santa Cruz, CA).
###end p 64
###begin title 65
Electrophoresis mobility shift assay
###end title 65
###begin p 66
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000997-Wang1">[26]</xref>
###xml 311 312 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 320 322 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Nuclear extracts were prepared as described previously [26]. 10-microg aliquots of cell nuclear extracts were pre-incubated with 1 microg of poly(dI-dc) in binding buffer (10 mM Tris [pH 7.7], 50 mM NaCl, 20% glycerol, 1 mM dithiothreitol [DTT], 0.5 mM EDTA) for 10 min at room temperature. Approximately 1.5x104 cpm of 32P-labeled DNA probes were then added and the reaction proceeded for 30 min. The specificity of the binding was further confirmed by anti-P65 or anti-P50 antibodies (Santa Cruz). The sequence for the probe was 5'-AGTTGAGGGGACTTTCCCAGGC-3'. The sequence for the probe was 5'-AGTTGAGGGGACTTTCCCAGGC-3'. The complexes were resolved on a 5% polyacrylamide gel in Tris-glycine buffer consisting of 25 mM Tris, 190 mM glycine and 1 mM EDTA at room temperature. The gel was dried at 80degreesC for 60 min and exposed to an X-ray film.
###end p 66
###begin title 67
NFkappaB activity reporter assay
###end title 67
###begin p 68
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Peritoneal cells extracted from WT and the Siglecg-/- mice were cultured in RPMI medium containing 10% FBS for overnight. Next day, the cells were transfected with NF-kappaB reporter plasmid of NF-kappaB-TA-luc (Clontech, San Diego, CA) by using Lipofectamine 2000 in 10% FBS Opti-MEM medium for 16 hours, and recovered in fresh complete RPMI medium for additional 12 to 16 hours. Plasmid Renilla luciferase (PRLSV40) was used as internal control for monitoring transfection efficiency.
###end p 68
###begin title 69
Bone marrow chimera
###end title 69
###begin p 70
###xml 34 44 34 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Siglecg&#8722;/&#8722;</italic>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
Bone marrow cells from WT and the Siglecg-/- mice were mixed at a 1:1 ratio (2.5x106 each) and were injected into lethally irradiated (1100 RAD) WT or Siglecg-/- mice. The bone marrow, spleen, lymph node and peritoneal lavages were harvested at 13 weeks after irradiation and analyzed by flow cytometry.
###end p 70
###begin title 71
In vivo treatment with IKK inhibitor
###end title 71
###begin p 72
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
5-day old siglecG-/- mice were treated with 0.01 mg of IKK inhibitor VI (Calbiochem, San Diego, CA) intra-peritoneally twice daily for 8 days and spleen and peritoneal cavity cells were harvested for analysis.
###end p 72
###begin title 73
Statistics
###end title 73
###begin p 74
The statistical significances of observed differences were analyzed by student t-tests. *, 0.05>P>0.01; **, 0.01>P>0.001; ***, P<0.001.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 1272 1276 <span type="species:ncbi:10090">mice</span>
###xml 1349 1353 <span type="species:ncbi:10090">mice</span>
Generation of Siglecg-/- mice that expressed green fluorescence protein (GFP) under the control of Siglecg regulatory sequence. A. Diagram of construct (top), siglecg genomic structure (middle) and the recombinant knock-out/in allele (bottom). Top, diagram of the knock-out/in construct. LA, long arm that ended before the Siglecg coding sequence in exon 2, SA, short arm consisting of 1.8 kb intron 2 sequence. GFP coding sequence is linked to exon 2 with its own stop codon and polyadenylations sites. Neo sequence is transcribed from the opposite direction. Middle, genomic structure, shaded area indicates coding sequence from exon 2 to 12. Bottom, the structure of the knock-in allele. The primers used are marked. B. Verification of homologous recombination by PCR. Data shown were for clone 361, which was used to generate the knockout/in mice. Integration of the construction is confirmed by AT1/N1 primer pair, while integration is confirmed by A1/N1, A2/N1 and A3/N1 pairs. The AT1/AT2 pair was the positive control for PCR. The primer sequences are: Primers used: A1: agctaagcacatgtgatggcta, A2: aggtgaataagtataggcccggc, A3: tgtgtgacctcaaggttgctc, AT1: tcagagtctcacttaccactcc, AT2: tattcagaggagtctgtggc, N1: tgcgaggccagaggccacttgtgtagc. C. Genotyping of the F2 mice using primers that identify WT, heterozygous and homozygous knockout/in mice. Primers used: siglecg-F: tcccagacttgcatgagaatc, silgecg-R: atgttctctctggaccagagg, GFP-F: atgtgatcgcgcttctcgtt, GFP-R: gagcgcaccatcttcttcaa. Product size: sigecg: 800bp, GFP: 280bp.
###end p 76
###begin p 77
(2.72 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
Preferential proliferation of mature B1a cells does not explain the expansion of B1a compartment in the Siglecg-deficient mice. A. Proliferation of splenic B1 B cells of 2- (top) and 10 (bottom)-weeks old mice. B. Proliferation of peritoneal B1a B cells from 10 week old mice. Two or 10 weeks-old Siglecg-/- and Siglecg+/+ mice were injected (ip) with 1 mg of BrdU 27 and 3 hours before sacrifice. Spleen and peritoneal B-1 a proliferation is analyzed by BrdU incorporation. The gates used were shown in the left. Profiles of BrdU incorporation is shown in the middle, while the summary data are shown in the right. Data shown are representative of 3 independent experiments.
###end p 79
###begin p 80
(3.46 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000997.s002">Fig. S2</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Siglecg does not control apoptosis of the B1B cells. Data shown are histograms depicting annexin V staining of ex vivo splenic (A) or peritoneal B1a B cells of 10-week old mice. The gates applied are the same as Fig. S2.
###end p 82
###begin p 83
(3.11 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 60 64 <span type="species:ncbi:10090">mice</span>
No increase of B1a B cells in bone marrow in the Siglecg-/- mice.
###end p 85
###begin p 86
(0.92 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 192 198 192 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000997-g004">Fig. 4</xref>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Siglecg-deficient bone marrow cells have competitive disadvantages in reconstituting spleen B1 subsets in lethally irradiated recipients. Spleen cells used were from chimera mice described in Fig. 4 legends.
###end p 88
###begin p 89
(2.61 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
We thank Chong Cheng for helpful discussion and Todd Brown for secretarial assistance.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
B cell development pathways.
###end article-title 93
###begin article-title 94
###xml 10 16 <span type="species:ncbi:10090">murine</span>
Origin of murine B cell lineages.
###end article-title 94
###begin article-title 95
A developmental switch in B lymphopoiesis.
###end article-title 95
###begin article-title 96
Positive selection of natural autoreactive B cells.
###end article-title 96
###begin article-title 97
Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development.
###end article-title 97
###begin article-title 98
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice.
###end article-title 98
###begin article-title 99
B Cell-Specific Deletion of Protein-Tyrosine Phosphatase Shp1 Promotes B-1a Cell Development and Causes Systemic Autoimmunity.
###end article-title 99
###begin article-title 100
The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.
###end article-title 100
###begin article-title 101
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Hyperresponsive B cells in CD22-deficient mice.
###end article-title 101
###begin article-title 102
CD22 regulates thymus-independent responses and the lifespan of B cells.
###end article-title 102
###begin article-title 103
###xml 15 19 <span type="species:ncbi:10090">mice</span>
CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.
###end article-title 103
###begin article-title 104
###xml 137 141 <span type="species:ncbi:10090">mice</span>
CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
###end article-title 104
###begin article-title 105
Siglecs and their roles in the immune system.
###end article-title 105
###begin article-title 106
Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1.
###end article-title 106
###begin article-title 107
A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
###end article-title 107
###begin article-title 108
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Sialoadhesin-deficient mice exhibit subtle changes in B- and T-cell populations and reduced immunoglobulin M levels.
###end article-title 108
###begin article-title 109
###xml 106 111 <span type="species:ncbi:9606">human</span>
Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
###end article-title 109
###begin article-title 110
###xml 80 85 <span type="species:ncbi:9606">human</span>
Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.
###end article-title 110
###begin article-title 111
Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
###end article-title 111
###begin article-title 112
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine B cell differentiation lineages.
###end article-title 112
###begin article-title 113
The protean nature of cells in the B lymphocyte lineage.
###end article-title 113
###begin article-title 114
Identification of a B-1 B cell-specified progenitor.
###end article-title 114
###begin article-title 115
NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.
###end article-title 115
###begin article-title 116
Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.
###end article-title 116
###begin article-title 117
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse.
###end article-title 117
###begin article-title 118
Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.
###end article-title 118
###begin article-title 119
Fundamental Immunology. Fifth ed.
###end article-title 119
###begin p 120
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 120
###begin p 121
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work is supported by National Institutes of Health, USA and Biomedical Research Technology Transfer fund of the State of Ohio. Neither has any role of any sponsors or funders in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.
###end p 121

